Physician profile
Shannon E Sullivan
NPI 1255673463
$118,131.69
in general payments reported to CMS, 2019-2025
7 companies · $8,547 in 2025
The $8,547 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,121 · 2020: $21K · 2021: $7,233 · 2022: $19K · 2023: $24K · 2024: $30K · 2025: $8,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $48K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $2,203 · Travel and Lodging: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $48,072.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,500.00 |
| Food and Beverage | $2,203.10 |
| Travel and Lodging | $842.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $117,893.11 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Astellas Pharma US INC | $72.99 | 2023 | |
| Abbvie INC. | $71.59 | 2020-2023 | Liletta |
| Therapeuticsmd, INC. | $38.00 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.15 | 2024 | |
| Sumitomo Pharma America, INC. | $17.00 | 2024 | Myfembree |
| Mayne Pharma Commercial LLC | $14.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.